# Bioequivalence Study of Feniramidol HCl 400 mg Film Tablet (Pharmactive, Turkey) Under Fed Conditions

> **NCT04639869** · PHASE1 · COMPLETED · sponsor: **Humanis Saglık Anonim Sirketi** · enrollment: 44 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** Phenyramydol HCl 400 mg Film Tablet
- **DRUG:** Cabral 400 mg Film Tablet

## Key facts

- **NCT ID:** NCT04639869
- **Lead sponsor:** Humanis Saglık Anonim Sirketi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-26
- **Primary completion:** 2019-07-26
- **Final completion:** 2019-08-27
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2023-09-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04639869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04639869, "Bioequivalence Study of Feniramidol HCl 400 mg Film Tablet (Pharmactive, Turkey) Under Fed Conditions". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04639869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*